In addition, studies in CRC and breast cancers have shown that high TM9SF4 expression may promote chemoresistance and that knocking down the gene is not only for inhibiting tumor progression but also for enhancing chemotherapeutic sensitivity (33, 35). Here, TM9SF4 is linked to breast cancer.